Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Companion Diagnostic Tests in Oncology market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Companion Diagnostic Tests in Oncology market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Protein Detection DNA Detection Segmented by End User/Segment Pharmaceutical & Biotechnology Companies Medical Device Companies Research Institutes Others Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Thermo Fisher Siemens Healthcare Roche QIAGEN Illumina Genomic Health BioMerieux Agilent Agendia Abbott

List of Figures

Figure Companion Diagnostic Tests in Oncology Picture
Figure Global Companion Diagnostic Tests in Oncology Sales Value (Million USD) and Growth Rate (2016-2027)
Figure Global Companion Diagnostic Tests in Oncology Sales Value CAGR (2020-2027) by Region
Figure Global Companion Diagnostic Tests in Oncology Sales Value Market Share by Company, 2020
Figure Product Picture of Protein Detection
Figure Product Picture of DNA Detection
Figure Global Companion Diagnostic Tests in Oncology Sales Value Market Share by Category, 2020
Figure North America Companion Diagnostic Tests in Oncology Sales Value Market Share by Category, 2020
Figure Europe Companion Diagnostic Tests in Oncology Sales Value Market Share by Category, 2020
Figure Asia Pacific Companion Diagnostic Tests in Oncology Sales Value Market Share by Category, 2020
Figure Central & South America Companion Diagnostic Tests in Oncology Sales Value Market Share by Category, 2020
Figure Middle East & Africa Companion Diagnostic Tests in Oncology Sales Value Market Share by Category, 2020
Figure Companion Diagnostic Tests in Oncology in Pharmaceutical & Biotechnology Companies
Figure Global Companion Diagnostic Tests in Oncology Market: Pharmaceutical & Biotechnology Companies (2016-2021)
Figure Companion Diagnostic Tests in Oncology in Medical Device Companies
Figure Global Companion Diagnostic Tests in Oncology Market: Medical Device Companies (2016-2021)
Figure Companion Diagnostic Tests in Oncology in Research Institutes
Figure Global Companion Diagnostic Tests in Oncology Market: Research Institutes (2016-2021)
Figure Companion Diagnostic Tests in Oncology in Others
Figure Global Companion Diagnostic Tests in Oncology Market: Others (2016-2021)
Figure Global Companion Diagnostic Tests in Oncology Sales Value Market Share by End User/Segment, 2020
Figure North America Companion Diagnostic Tests in Oncology Sales Value Market Share by End User/Segment, 2020
Figure Europe Companion Diagnostic Tests in Oncology Sales Value Market Share by End User/Segment, 2020
Figure Asia Pacific Companion Diagnostic Tests in Oncology Sales Value Market Share by End User/Segment, 2020
Figure Central & South America Companion Diagnostic Tests in Oncology Sales Value Market Share by End User/Segment, 2020
Figure Middle East & Africa Companion Diagnostic Tests in Oncology Sales Value Market Share by End User/Segment, 2020
Figure Global Companion Diagnostic Tests in Oncology Sales Value Market Share by Region (2016-2021)
Figure North America Companion Diagnostic Tests in Oncology Sales Value (Million USD) Status (2016-2021)
Figure Europe Companion Diagnostic Tests in Oncology Sales Value (Million USD) Status (2016-2021)
Figure Asia Pacific Companion Diagnostic Tests in Oncology Sales Value (Million USD) Status (2016-2021)
Figure Central & South America Companion Diagnostic Tests in Oncology Sales Value (Million USD) Status (2016-2021)
Figure Middle East & Africa Companion Diagnostic Tests in Oncology Sales Value (Million USD) Status (2016-2021)
Figure North America Companion Diagnostic Tests in Oncology Sales Value Market Share by Country, 2020
Figure United States Companion Diagnostic Tests in Oncology Sales Value (Million USD) Status (2016-2021)
Figure Canada Companion Diagnostic Tests in Oncology Sales Value (Million USD) Status (2016-2021)
Figure Mexico Companion Diagnostic Tests in Oncology Sales Value (Million USD) Status (2016-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Companion Diagnostic Tests in Oncology Market Status and Forecast (2016-2027) 1.3.2 Global Companion Diagnostic Tests in Oncology Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Companion Diagnostic Tests in Oncology Supply by Company 2.1 Global Companion Diagnostic Tests in Oncology Sales Value by Company 2.2 Companion Diagnostic Tests in Oncology Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional Companion Diagnostic Tests in Oncology Market Status by Category 3.1 Companion Diagnostic Tests in Oncology Category Introduction 3.1.1 Protein Detection 3.1.2 DNA Detection 3.2 Global Companion Diagnostic Tests in Oncology Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Companion Diagnostic Tests in Oncology Market Status by End User/Segment 4.1 Companion Diagnostic Tests in Oncology Segment by End User/Segment 4.1.1 Pharmaceutical & Biotechnology Companies 4.1.2 Medical Device Companies 4.1.3 Research Institutes 4.1.4 Others 4.2 Global Companion Diagnostic Tests in Oncology Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Companion Diagnostic Tests in Oncology Market Status by Region 5.1 Global Companion Diagnostic Tests in Oncology Market by Region 5.2 North America Companion Diagnostic Tests in Oncology Market Status 5.3 Europe Companion Diagnostic Tests in Oncology Market Status 5.4 Asia Pacific Companion Diagnostic Tests in Oncology Market Status 5.5 Central & South America Companion Diagnostic Tests in Oncology Market Status 5.6 Middle East & Africa Companion Diagnostic Tests in Oncology Market Status6 North America Companion Diagnostic Tests in Oncology Market Status 6.1 North America Companion Diagnostic Tests in Oncology Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Companion Diagnostic Tests in Oncology Market Status 7.1 Europe Companion Diagnostic Tests in Oncology Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Companion Diagnostic Tests in Oncology Market Status 8.1 Asia Pacific Companion Diagnostic Tests in Oncology Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Companion Diagnostic Tests in Oncology Market Status 9.1 Central & South America Companion Diagnostic Tests in Oncology Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Companion Diagnostic Tests in Oncology Market Status 10.1 Middle East & Africa Companion Diagnostic Tests in Oncology Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global Companion Diagnostic Tests in Oncology Market Forecast by Category and by End User/Segment 12.1 Global Companion Diagnostic Tests in Oncology Sales Value Forecast (2022-2027) 12.2 Global Companion Diagnostic Tests in Oncology Forecast by Category 12.3 Global Companion Diagnostic Tests in Oncology Forecast by End User/Segment13 Global Companion Diagnostic Tests in Oncology Market Forecast by Region/Country 13.1 Global Companion Diagnostic Tests in Oncology Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Thermo Fisher 14.1.1 Company Information 14.1.2 Companion Diagnostic Tests in Oncology Product Introduction 14.1.3 Thermo Fisher Companion Diagnostic Tests in Oncology Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 Siemens Healthcare 14.2.1 Company Information 14.2.2 Companion Diagnostic Tests in Oncology Product Introduction 14.2.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 Roche 14.3.1 Company Information 14.3.2 Companion Diagnostic Tests in Oncology Product Introduction 14.3.3 Roche Companion Diagnostic Tests in Oncology Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 QIAGEN 14.4.1 Company Information 14.4.2 Companion Diagnostic Tests in Oncology Product Introduction 14.4.3 QIAGEN Companion Diagnostic Tests in Oncology Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 Illumina 14.5.1 Company Information 14.5.2 Companion Diagnostic Tests in Oncology Product Introduction 14.5.3 Illumina Companion Diagnostic Tests in Oncology Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis 14.6 Genomic Health 14.6.1 Company Information 14.6.2 Companion Diagnostic Tests in Oncology Product Introduction 14.6.3 Genomic Health Companion Diagnostic Tests in Oncology Sales Value, Gross Margin and Global Share (2019-2021) 14.6.4 SWOT Analysis 14.7 BioMerieux 14.7.1 Company Information 14.7.2 Companion Diagnostic Tests in Oncology Product Introduction 14.7.3 BioMerieux Companion Diagnostic Tests in Oncology Sales Value, Gross Margin and Global Share (2019-2021) 14.7.4 SWOT Analysis 14.8 Agilent 14.8.1 Company Information 14.8.2 Companion Diagnostic Tests in Oncology Product Introduction 14.8.3 Agilent Companion Diagnostic Tests in Oncology Sales Value, Gross Margin and Global Share (2019-2021) 14.8.4 SWOT Analysis 14.9 Agendia 14.9.1 Company Information 14.9.2 Companion Diagnostic Tests in Oncology Product Introduction 14.9.3 Agendia Companion Diagnostic Tests in Oncology Sales Value, Gross Margin and Global Share (2019-2021) 14.9.4 SWOT Analysis 14.10 Abbott 14.10.1 Company Information 14.10.2 Companion Diagnostic Tests in Oncology Product Introduction 14.10.3 Abbott Companion Diagnostic Tests in Oncology Sales Value, Gross Margin and Global Share (2019-2021) 14.10.4 SWOT Analysis15 Conclusion16 Methodology